The online version of this article (doi:10.1186/1752-1947-8-288) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
FA analyzed and interpreted the patient data regarding the hematological disease and the transplant. FA, FG and NM performed the histological examination, and NM was a major contributor in writing the manuscript. All authors read and approved the final manuscript.
Systemic Epstein-Barr virus-positive T-cell lymphoproliferative childhood disease is an extremely rare disorder and classically arises following primary acute or chronic active Epstein-Barr virus infection. It is characterized by clonal proliferation of Epstein-Barr virus-infected T-cells with an activated cytotoxic phenotype. This disease has a rapid clinical course and is more frequent in Asia and South America, with relatively few cases being reported in Western countries. The clinical and pathological features of the disease overlap with other conditions including infectious mononucleosis, chronic active Epstein-Barr virus infection, hemophagocytic lymphohistiocytosis and natural killer cell malignancies. We describe the rare case of systemic Epstein-Barr virus-positive T-cell lymphoproliferative childhood disease in a 16-year-old Malay boy.
He presented with a six-month history of fever and cough, with pulmonary and mediastinal lymphadenopathy and severe pancytopenia. Medium- to large-sized, CD8+ and Epstein-Barr virus-encoded RNA-positive atypical lymphoid cells were present in the bone marrow aspirate. He subsequently developed fatal virus-associated hemophagocytic syndrome and died due to sepsis and multiorgan failure.
Although systemic Epstein-Barr virus-positive T-cell lymphoproliferative childhood disease is a disorder which is rarely encountered in clinical practice, our case report underlines the importance of a comprehensive diagnostic approach in the management of this disease. A high level of awareness of the disease throughout the diagnosis process for young patients who present with systemic illness and hemophagocytic syndrome may be of great help for the clinical diagnosis of this disease.
Cohen JI, Kimura H, Nakamura S, Ko YH, Jaffe ES: Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8â€“9 September 2008. Ann Oncol. 2009, 20: 1472-1482. 10.1093/annonc/mdp064. CrossRefPubMedPubMedCentral
Tabanelli V, Agostinelli C, Sabattini E, Gazzola A, Bacci F, Capria S, Mannu C, Righi S, Sista MT, Meloni G, Pileri SA, Piccaluga PP: Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: a case report and review of the literature. J Med Case Rep. 2011, 5: 218-10.1186/1752-1947-5-218. CrossRefPubMedPubMedCentral
Swerdlow S, Campo E, Harris N: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 2008, Lyon: International Agency for Research on Cancer, 4
Leeborg N, Russell T, Fan G: Systemic Epstein-Barr virus-positive t-cell lymphoproliferative disease of childhood. Pathol Case Rev. 2012, 17: 120-124. 10.1097/PCR.0b013e318258eeba. CrossRef
Ohno T, Miyake N, Hada S, Hirose Y, Imura A, Hori T, Uchiyama T, Saiga T, Mizumoto T, Furukawa H: Hemophagocytic syndrome in five patients with Epstein-Barr virus negative B-cell lymphoma. Cancer. 1998, 82: 1963-1972. 10.1002/(SICI)1097-0142(19980515)82:10<1963::AID-CNCR21>3.0.CO;2-Q. CrossRefPubMed
- Systematic Epstein-Barr virus-positive T-cell lymphoproliferative disease presenting as a persistent fever and cough: a case report
- BioMed Central